ILLUMID Trademark

Trademark Overview

On Friday, August 7, 2020, a trademark application was filed for ILLUMID with the United States Patent and Trademark Office. The USPTO has given the ILLUMID trademark a serial number of 90100698. The federal status of this trademark filing is ABANDONED - NO STATEMENT OF USE FILED as of Monday, April 8, 2024. This trademark is owned by Allergan Holdings France SAS. The ILLUMID trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical preparations for the treatment of asymmetries, volume deficits, defects and conditions of the human skin
illumid

General Information

Serial Number90100698
Word MarkILLUMID
Filing DateFriday, August 7, 2020
Status606 - ABANDONED - NO STATEMENT OF USE FILED
Status DateMonday, April 8, 2024
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, January 5, 2021

Trademark Statements

Goods and ServicesPharmaceutical preparations for the treatment of asymmetries, volume deficits, defects and conditions of the human skin

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateWednesday, September 9, 2020
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameAllergan Holdings France SAS
Party Type20 - Owner at Publication
Legal Entity Type99 - Other
AddressCourbevoie 92400
FR
Party NameAllergan Holdings France SAS
Party Type10 - Original Applicant
Legal Entity Type99 - Other
AddressCourbevoie 92400
FR

Trademark Events

Event DateEvent Description
Monday, April 8, 2024ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED
Monday, April 8, 2024ABANDONMENT - NO USE STATEMENT FILED
Friday, September 1, 2023NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Thursday, August 31, 2023SOU EXTENSION 5 GRANTED
Friday, August 25, 2023SOU EXTENSION 5 FILED
Thursday, August 31, 2023CASE ASSIGNED TO INTENT TO USE PARALEGAL
Friday, August 25, 2023SOU TEAS EXTENSION RECEIVED
Tuesday, February 21, 2023NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Friday, February 17, 2023SOU EXTENSION 4 GRANTED
Friday, February 17, 2023SOU EXTENSION 4 FILED
Friday, February 17, 2023SOU TEAS EXTENSION RECEIVED
Friday, February 10, 2023TEAS CHANGE OF CORRESPONDENCE RECEIVED
Friday, February 10, 2023TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS
Friday, February 10, 2023ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Friday, February 10, 2023TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Wednesday, August 3, 2022NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Monday, August 1, 2022SOU EXTENSION 3 GRANTED
Monday, August 1, 2022SOU EXTENSION 3 FILED
Monday, August 1, 2022SOU TEAS EXTENSION RECEIVED
Thursday, March 3, 2022NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Monday, February 28, 2022SOU EXTENSION 2 GRANTED
Monday, February 28, 2022SOU EXTENSION 2 FILED
Monday, February 28, 2022SOU TEAS EXTENSION RECEIVED
Tuesday, August 10, 2021NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Friday, August 6, 2021SOU EXTENSION 1 GRANTED
Friday, August 6, 2021SOU EXTENSION 1 FILED
Friday, August 6, 2021SOU TEAS EXTENSION RECEIVED
Tuesday, March 2, 2021NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, January 5, 2021OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, January 5, 2021PUBLISHED FOR OPPOSITION
Wednesday, December 16, 2020NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Wednesday, December 2, 2020APPROVED FOR PUB - PRINCIPAL REGISTER
Tuesday, December 1, 2020ASSIGNED TO EXAMINER
Wednesday, September 9, 2020NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Tuesday, August 11, 2020NEW APPLICATION ENTERED

Related Keywords

illumid defects conditions human skin deficits volume preparations treatment asymmetries pharmaceutical